Related Experiment Videos
5-HT2A antagonists in psychiatric disorders
1Department of Biomedical Sciences, University of Trieste, Italy. ldeangelis@spin.it
Abstract:
Several lines of evidence support a role for serotoninergic (5-HT) system abnormalities in the pathogenesis and treatment of several psychiatric disorders. This review summarizes information about the association between the 5-HT2A receptor gene and its relevance to schizophrenia, tardive dyskinesia, major depression, suicidality, anorexia nervosa and obsessive-compulsive disorder. Evidence is presented that implies that selective 5-HT2A antagonists may be considered useful in investigating the role of 5-HT2A receptor function and in the treatment of psychosis, and possibly alcohol and cocaine dependence. Additionally, findings are reviewed on the importance of 5-HT2A receptor antagonism in contributing to the therapeutic effect of several clinically effective and potential atypical antipsychotics as well as several antidepressants. In conclusion, the ability of selective 5-HT2A receptor antagonists to interfere with the heightened state of dopamine activity without altering basal tone, suggests that these drugs possess antipsychotic activity and may provide the basis for new therapies for psychosis and drug dependence, in addition to contributing towards a more complete understanding of 5-HT2A receptor function.
Insights
Serotonin (5-HT) system abnormalities are linked to psychiatric disorders. Selective 5-HT2A antagonists show promise for treating psychosis and drug dependence by modulating dopamine activity.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Serotonergic (5-HT) system dysregulation is implicated in the pathophysiology of various psychiatric conditions.
- The 5-HT2A receptor is a key target for understanding and treating these disorders.
Purpose of the Study:
- To review the association between the 5-HT2A receptor gene and psychiatric disorders.
- To explore the therapeutic potential of selective 5-HT2A antagonists in psychiatric and substance use disorders.
Main Methods:
- Literature review synthesizing evidence on 5-HT2A receptor gene associations.
- Analysis of studies investigating 5-HT2A antagonists in psychiatric and addiction models.
Main Results:
- Evidence links the 5-HT2A receptor to schizophrenia, major depression, and obsessive-compulsive disorder.
- Selective 5-HT2A antagonists demonstrate potential in treating psychosis, alcohol, and cocaine dependence.
- 5-HT2A receptor antagonism contributes to the efficacy of atypical antipsychotics and antidepressants.
Conclusions:
- Selective 5-HT2A antagonists may offer novel therapeutic strategies for psychosis and drug dependence.
- These agents modulate dopamine activity, suggesting antipsychotic properties without affecting basal tone.
- Further understanding of 5-HT2A receptor function is crucial for developing new treatments.